We’ve partnered with tertiary analysis platforms, Genomize, Geneyx, & Golden Helix to enhance our hereditary cancer panel. Combining their analysis expertise with Oxford Nanopore sequencing to provide more precise oncology insights.
Learn more: https://bit.ly/3QRnLgF
#AACR26
Learn more: https://bit.ly/3QRnLgF
#AACR26
April 22, 2026 at 2:15 PM
We’ve partnered with tertiary analysis platforms, Genomize, Geneyx, & Golden Helix to enhance our hereditary cancer panel. Combining their analysis expertise with Oxford Nanopore sequencing to provide more precise oncology insights.
Learn more: https://bit.ly/3QRnLgF
#AACR26
Learn more: https://bit.ly/3QRnLgF
#AACR26
#LatestNews We're thrilled to announce a powerful new partnership with #Genomize to integrate #MastermindGIP and #CKB! Read the full press release: www.genomenon.com/news-press-e...
March 27, 2025 at 1:36 PM
#LatestNews We're thrilled to announce a powerful new partnership with #Genomize to integrate #MastermindGIP and #CKB! Read the full press release: www.genomenon.com/news-press-e...
Genomize-SEQ: An NGS data analysis platform for genomic variant classification and prioritization https://www.medrxiv.org/content/10.1101/2025.09.05.25335160v1
September 8, 2025 at 12:40 AM
Genomize-SEQ: An NGS data analysis platform for genomic variant classification and prioritization https://www.medrxiv.org/content/10.1101/2025.09.05.25335160v1